Emily received her PhD from the University of Cambridge where she studied the impacts of immune dysregulation on the response to vaccination against SARS-CoV-2. In the lab of Dr James Thaventhiran at the MRC Toxicology Unit she explored how obesity and IL-6 signaling influence the B cell response triggered by mRNA vaccines.
In the group of Dr Claudia Ribeiro de Almeida she investigates the role of RNA helicases in the germinal centre responses of B cells.